Nevertheless, these methylation-wide association studies (MWAS) have revealed common methylation changes at a number of AD risk loci such as ANK1, BIN1, RHBDF2, HOXA3, CDH23, and RPL13 [56–61], providing relatively strong evidence that methylation of these genetic loci may be altered in AD. This evidence concerns the gene HOXA3 and Alzheimer disease.